Phase
Condition
Bipolar Disorder
Mood Disorders
Treatment
tACS brain stimulation treatment
Sham stimulation treatment
Clinical Study ID
Ages 18-55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Confirmed diagnosis of BD based on Diagnostic and Statistical Manual of MentalDisorders Fourth Edition (DSM-IV) criteria being met from previous enrollment in thePrechter Bipolar Longitudinal Study
This study will select BD patients that scored above published norms (upper 50thpercentile) on the NEO-PI impulsivity facet to ensure that the recruited patientsexhibit the network dysfunction targeted by the tACS paradigm and therefore have thepotential to benefit from this neuromodulation technique.
Patients must be on a stable dose of medication for two weeks prior to Sessions 2and 3.
Exclusion
Exclusion Criteria:
Significant neurological abnormalities, such as seizure disorder, mass lesions, etc.
Known Mendelian disorder
Active problematic substance use in the past 30 days (as determined by the SubstanceUse Disorder module of SCID)
Evidence of suicidal intentions or behaviors in the past month, as judged byaffirmative responses to question number 4 or number 5 on the Columbia SuicideSeverity Rating Scale (CSSRS) or report of suicidal behaviors in the last 6 months
Pregnant or trying to become pregnant, or currently lactating.
Study Design
Connect with a study center
University of Michigan
Ann Arbor, Michigan 48109
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.